Increased maternal serum 3 alpha, 17 beta-androstanediol glucuronide concentrations during pregnancy

Area of Science:

• Endocrinology
• Reproductive Biology
• Steroid Metabolism

Background:

• Peripheral androgen action and 5 alpha-reductase activity are crucial in reproductive health.
• 3 alpha, 17 beta-androstanediol glucuronide (3 alpha-diol-G) is a key biomarker for these processes.
• Understanding hormonal changes during pregnancy is vital for maternal and fetal well-being.

Purpose of the Study:

• To measure maternal serum 3 alpha-diol-G concentrations in pregnant and nonpregnant women, as well as in men.
• To investigate the relationship between 3 alpha-diol-G levels and pregnancy status.
• To explore potential fetal sex differences in 3 alpha-diol-G levels.

Main Methods:

• Serum samples were collected from 33 normal men, 51 nonpregnant women, and 51 women with uncomplicated pregnancies.
• Concentrations of 3 alpha-diol-G were quantified using established laboratory assays.
• Statistical analyses were performed to compare concentrations across different groups and trimesters.

Main Results:

• Maternal serum 3 alpha-diol-G concentrations were significantly higher in pregnant women (median, 124 ng/ml) compared to nonpregnant women (median, 42 ng/ml).
• Men exhibited the highest concentrations (median, 201 ng/ml), significantly exceeding those in both nonpregnant and pregnant women.
• No significant differences in maternal 3 alpha-diol-G were observed between pregnancy trimesters, nor were fetal sex differences detected in maternal serum or amniotic fluid.

Conclusions:

• Pregnancy is associated with increased androgen production by maternal tissues.
• Maternal 5 alpha-reductase activity, reflected by 3 alpha-diol-G, is elevated during pregnancy.
• Fetal contribution to serum 3 alpha-diol-G levels appears minimal during pregnancy.